New indication discovery (IND) computational research service

Home | Careers | Contact us

Products

Technology

Services

About us

SERVICES NEWS

Sun Pharma
enters into agreement with VLife

PRODUCTS NEWS

IndiSwitch
Product Lifecycle Management with valuable IP

In the prevailing patent regime, the discovery of New Indications for approved drugs acts as an important Product Lifecycle Management strategy.

If you have a product in the market which is getting off-patent or a product that is not meeting its business objectives in the approved area, we can help you in discovering new indications where it can have a protectable intellectual property position.

We undertake New Indication research deploying three independent approaches which ensure extensive exploration and hardly leave chance of false negatives and false positives. This research is carried out by expert VLife scientists who have a sterling track record in discovery of new indications and is enabled by our computational technologies and a multi core parallel processing computational cluster.

We cover the following work-flow with the scope of engagement with client covering some or all of the following steps:

Computational discovery research
Novelty search and provisional patent filing
In-vitro testing & lead optimization
Full application filing under PCT
Assignment of the filed patent to the client

Connect with VLife Expert to know more about this offering and how VLife can create intellectual property for you.

VLife services track record

VLife’s research team has over 300 man years of research experience. VLife Research Services is credited with:

  •  Design and discovery of 3 NCEs
  •  7 new indication discoveries
  •  Several activity specific research

IndiSwitch Case studies

  •  Finding new targets for existing       compound for new indications
  •  Compare clients molecule against
      existing drug for GPCR targets

Download here

THE VLIFE SERVICES ADVANTAGE

Our expertise in computational discovery
Success with computation technology requires awareness of not only its strengths but also of the areas where it needs augmentation from other approaches. Being developers of computational technologies, we have proved our expertise by creating IP in 3 NCE classes and 7 new indication discoveries.

Wide diversity of experience
We cater to a variety of sectors and within them, a diversity of areas. e.g. in pharmaceuticals, we have successfully delivered discovery projects in oncology, anti-fungal, diabetes, CNS etc.

State-of-art technology portfolio
Clients benefit from the whole range of VLife's technologies having validated algorithms, published innovations and efficient workflows which are accessible to clients through VLife services.

In-house custom development skills
Generic technologies sometimes are inadequate or inefficient in complex research. For such needs, our in-house team has skills to develop custom technologies ensuring reliable research.

Case studies: VLife services

	Finding new indications of existing drugs View
	Phosphorylation Vs Glycosylation in targets of hexosamine biosynthetic pathway View
	Development and screening of NMDA agonist View